Ju‐Seop Kang

772 total citations
48 papers, 602 citations indexed

About

Ju‐Seop Kang is a scholar working on Molecular Biology, Analytical Chemistry and Pharmacology. According to data from OpenAlex, Ju‐Seop Kang has authored 48 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Analytical Chemistry and 8 papers in Pharmacology. Recurrent topics in Ju‐Seop Kang's work include Analytical Methods in Pharmaceuticals (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Ju‐Seop Kang is often cited by papers focused on Analytical Methods in Pharmaceuticals (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Ju‐Seop Kang collaborates with scholars based in South Korea, United States and United Kingdom. Ju‐Seop Kang's co-authors include Ae‐Son Om, Leslie M. Shaw, Young Moo Lee, So Yeon Kim, Hyeon‐Jin Shin, Shin‐Hee Kim, Dong Sun Kim, Qiuyang Wang, Jung Mogg Kim and Inhye Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

In The Last Decade

Ju‐Seop Kang

47 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju‐Seop Kang South Korea 15 158 80 71 62 61 48 602
Jung‐woo Chae South Korea 15 201 1.3× 117 1.5× 126 1.8× 74 1.2× 32 0.5× 95 778
Suneela Dhaneshwar India 16 270 1.7× 124 1.6× 70 1.0× 63 1.0× 64 1.0× 65 841
Kyeong‐Ryoon Lee South Korea 16 239 1.5× 68 0.8× 179 2.5× 41 0.7× 52 0.9× 70 790
Mingming Zhao China 19 228 1.4× 118 1.5× 114 1.6× 55 0.9× 44 0.7× 70 866
Abhishek Yadav India 18 127 0.8× 48 0.6× 52 0.7× 27 0.4× 22 0.4× 44 968
Safaa Qusti Saudi Arabia 16 221 1.4× 68 0.8× 33 0.5× 76 1.2× 22 0.4× 43 938
Dominik Selzer Germany 17 149 0.9× 63 0.8× 122 1.7× 33 0.5× 66 1.1× 44 963
Raj Badhan United Kingdom 18 154 1.0× 63 0.8× 155 2.2× 52 0.8× 24 0.4× 43 787
Cordula Stillhart Switzerland 17 132 0.8× 67 0.8× 167 2.4× 19 0.3× 95 1.6× 32 883
Ji-Hun Jang South Korea 16 298 1.9× 78 1.0× 69 1.0× 90 1.5× 19 0.3× 85 985

Countries citing papers authored by Ju‐Seop Kang

Since Specialization
Citations

This map shows the geographic impact of Ju‐Seop Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Seop Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Seop Kang more than expected).

Fields of papers citing papers by Ju‐Seop Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju‐Seop Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Seop Kang. The network helps show where Ju‐Seop Kang may publish in the future.

Co-authorship network of co-authors of Ju‐Seop Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Ju‐Seop Kang. A scholar is included among the top collaborators of Ju‐Seop Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju‐Seop Kang. Ju‐Seop Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Kang, Ju‐Seop, et al.. (2023). MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors. Korean Journal of Physiology and Pharmacology. 27(3). 241–256. 5 indexed citations
4.
Kang, Ju‐Seop, et al.. (2022). Deubiquitinase USP19 enhances phenylalanine hydroxylase protein stability and its enzymatic activity. Cell Biology and Toxicology. 39(5). 2295–2310. 6 indexed citations
5.
Kang, Ju‐Seop, et al.. (2022). Effect of Metformin on Myocardial Injury Induced by Hepatic Ischemia-Reperfusion in Rats. Frontiers in Pharmacology. 13. 822743–822743. 8 indexed citations
6.
Kim, Tae‐Eun, et al.. (2022). Systemic exposure to propranolol in patients with chronic liver disease and its correlation with portal blood flow. Frontiers in Medicine. 9. 973606–973606. 1 indexed citations
7.
Kang, Ju‐Seop, et al.. (2021). Cardiac biomarkers and COVID-19: A systematic review and meta-analysis. Journal of Infection and Public Health. 14(9). 1191–1197. 19 indexed citations
8.
Kang, Ju‐Seop, et al.. (2017). Quantification of Etodolac in Human Plasma for Pharmacokinetics and Bioequivalence Studies in 27 Korean Subjects. Drug Metabolism Letters. 10(4). 286–294. 2 indexed citations
9.
Kim, Hyun‐Jin, et al.. (2014). Quantification of propranolol in rat plasma by LC- MS/MS using tramadol as an internal standard: Application to pharmacokinetic studies in TAA-induced liver fibrotic rats. African Journal of Pharmacy and Pharmacology. 8(13). 356–363. 1 indexed citations
10.
Lee, Min‐Ho, et al.. (2013). 201Tl Heart-Liver Radioactivity Uptake Ratio and Prediction of Decompensation in Patients With Cirrhosis. Clinical Nuclear Medicine. 38(3). 169–174. 2 indexed citations
11.
Kim, Seo Yun, Ju‐Seop Kang, Sang‐Min Lee, et al.. (2009). TREATMENT OUTCOME AND ADVERSE EFFECT IN ELDERLY TUBERCULOSIS PATIENTS ACCORDING TO COMORBIDITIES. CHEST Journal. 136(4). 44S–44S. 1 indexed citations
12.
Park, Jinhee, et al.. (2009). Rapid quantification of levosulpiride in human plasma using RP‐HPLC‐MS/MS for pharmacokinetic and bioequivalence study. Biomedical Chromatography. 23(12). 1350–1356. 8 indexed citations
14.
Park, Jinhee, et al.. (2008). Determination of plasma topiramate concentration using LC‐MS/MS for pharmacokinetic and bioequivalence studies in healthy Korean volunteers. Biomedical Chromatography. 22(8). 822–829. 21 indexed citations
15.
Park, Jinhee, et al.. (2008). Quantification of isradipine in human plasma using LC–MS/MS for pharmacokinetic and bioequivalence study. Journal of Chromatography B. 877(1-2). 59–64. 21 indexed citations
16.
Shaw, Leslie M., et al.. (2004). Using Established Immunosuppressant Therapy Effectively. Therapeutic Drug Monitoring. 26(4). 347–351. 39 indexed citations
17.
Kim, So Yeon, Young Moo Lee, Hyeon‐Jin Shin, & Ju‐Seop Kang. (2001). Indomethacin-loaded methoxy poly(ethylene glycol)/poly(ε-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague–Dawley rats. Biomaterials. 22(14). 2049–2056. 61 indexed citations
18.
Kang, Ju‐Hee, Woon‐Gye Chung, Kyung‐Hoon Lee, et al.. (2000). Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population. Pharmacogenetics. 10(1). 67–78. 46 indexed citations
19.
Kim, Bum Soo, et al.. (2000). Mediation of the cardiovascular response to spinal γ-aminobutyric acidB receptor stimulation by adenosine A1 receptors in anesthetized rats. Neuroscience Letters. 296(2-3). 153–157. 8 indexed citations
20.
Lee, Chang Ho, et al.. (1998). Differential coupling of Gαq family of G-protein to muscarinic M1 receptor and neurokinin-2 receptor. Archives of Pharmacal Research. 21(4). 423–428. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026